The word “candidate” is often used when determining whether a patient with HF will benefit from a particular therapy, but an editorial in the Journal of Cardiac Failure states the term may be too judgmental.
“Imagine for a moment that you are a patient, being told you are not a ‘candidate’ for a given therapy,” wrote Anuradha (Anu) Lala, MD, associate professor of medicine (cardiology) and population health and science policy at Icahn School of Medicine at Mount Sinai and deputy editor of the Journal of Cardiac Failure, and Robert J. Mentz, MD, associate